News - The ��

Emerging class of antibiotics to tackle global TB crisis

The rise of drug-resistant tuberculosis strains has made the search for new treatments increasingly urgent.
Article link /content/dam/corporate/images/news-and-opinion/news/2026/february/generic-x-ray-of-tuberculosis-patient.-adobe-images.jpeg 1280.1280.jpeg 1280w, 440.293.2x.jpeg 880w, 1440.960.2x.jpeg 2880w, 800.533.2x.jpeg 1600w, 220.147.2x.jpeg 440w 26 February 2026
Sugar molecules point to a new weapon against drug-resistant bacteria

A bacterial sugar becomes an unexpected Achilles' heel for deadly pathogens.
Article link /content/dam/corporate/images/news-and-opinion/news/2026/february/antibody-binding-the-pse-sugar-to-target-bacteria-with-this-sugar-for-destruction---wehi.jpg 1280.1280.jpeg 1280w, 220.231.2x.jpeg 440w, 1440.1511.2x.jpeg 2880w, 440.462.2x.jpeg 880w, 800.839.2x.jpeg 1600w 5 February 2026
Sydney scholar Richard Payne honoured with Australian Laureate Fellowship

His research will investigate how proteins can advance the biotech and pharmaceutical sectors.
Article link /content/dam/people/a.-professor-richard-payne-faa.-school-of-chemistry.-the-university-of-sydney.-newly-elected-as-a-fellow-of-the-australian-academy-of-science.-photo-by-stefanie-zingsheim.jpg 1280.1280.jpeg 1280w, 800.450.2x.jpeg 1600w, 440.247.2x.jpeg 880w, 220.124.2x.jpeg 440w 30 June 2025
Native bee honey has potential in the fight against antibiotic resistance

'Sugarbag' honey, historically used by First Nations peoples, could scale commercially.
Article link /content/dam/corporate/images/news-and-opinion/news/2025/may/sugarbag-bee-beehives---tetragonula-carbonaria.-adobe-images.jpeg 1280.1280.jpeg 1280w, 1440.810.2x.jpeg 2880w, 440.248.2x.jpeg 880w, 800.451.2x.jpeg 1600w, 220.124.2x.jpeg 440w 23 June 2025
NSW Organoid Innovation Centre launches at Sydney

'Organs in a dish' technology to accelerate personalised medicine and drug discovery.
Article link /content/dam/corporate/images/news-and-opinion/news/2025/april/nswoic-launch-26mar25-hugh-durrant-whyte-left-michael-kassiou-right.jpg 800.534.2x.jpeg 1600w, 2000.1334.2x.jpeg 4000w, 1280.1280.jpeg 1280w, 440.293.2x.jpeg 880w, 1440.960.2x.jpeg 2880w, 220.147.2x.jpeg 440w 2 April 2025
Professor Michael Kassiou wins the 2024 AFR Research Commercialisation award

The �� awarded at the AFR Higher Education Awards this year, with Kinoxis Therapeutics as joint winner.
Article link /content/dam/corporate/images/news-and-opinion/news/2024/august/img_3846(1).jpg 1440.790.2x.jpeg 2880w, 1280.1280.jpeg 1280w, 440.242.2x.jpeg 880w, 220.121.2x.jpeg 440w, 800.440.2x.jpeg 1600w 21 August 2024
Psylo partnership to deliver psychedelic treatments for mental health

A partnership between the �� Brain and Mind Centre and biotech startup Psylo will promises life-changing therapeutics for mental health treatment.
Article link /content/dam/brand-and-marketing-assets/conceptual-images/abstract-serotonin-adobe-images.jpg 800.350.2x.jpeg 1600w, 1280.1280.jpeg 1280w, 1440.630.2x.jpeg 2880w, 440.192.2x.jpeg 880w, 220.96.2x.jpeg 440w, 2000.1330.2x.jpeg 4000w 27 June 2024
Beyond CRISPR: seekRNA delivers a new pathway for accurate gene editing

Developed in the Ataide Laboratory at the ��, seekRNA is a programmable tool can precisely target and relocate genetic sequences, picking up from the work started by CRISPR gene-editing.
Article link /content/dam/brand-and-marketing-assets/conceptual-images/artists-impression-rna-strand-adobe-images.jpg 1280.1280.jpeg 1280w, 1440.630.2x.jpeg 2880w, 220.96.2x.jpeg 440w, 440.193.2x.jpeg 880w, 2000.1330.2x.jpeg 4000w, 800.351.2x.jpeg 1600w 25 June 2024
Drug discovery gets $9.75m boost for MedChem Australia

The �� will be one of three national nodes of MedChem Australia, established in partnership with Monash and WEHI Medical Research, which will accelerate early-stage drug discovery.
Article link /content/dam/people/professor-michael-kassiou-in-his-labs.-school-of-chemistry.-university-of-sydney.-03may23.-photo-is-by-stefanie-zingsheim.jpg 1280.1280.jpeg 1280w, 440.293.2x.jpeg 880w, 1440.810.2x.jpeg 2880w, 800.450.2x.jpeg 1600w, 800.533.2x.jpeg 1600w, 440.248.2x.jpeg 880w, 220.147.2x.jpeg 440w, 220.124.2x.jpeg 440w 27 June 2023
AI drug discovery will power collaboration with Pharos Therapeutics

A partnership between the ��'s Drug Discovery Initiative and Pharos Therapeutics will use artificial intelligence to more rapidly identify promising treatments for cancers and rare diseases.
Article link /content/dam/alumni-community-and-industry-engagement/university-partnerships/julie-cairney-kyu-tae-kim-michael-kassiou-pharos-mou-may-2023.jpg 1280.1280.jpeg 1280w, 1440.810.2x.jpeg 2880w, 800.450.2x.jpeg 1600w, 440.248.2x.jpeg 880w, 220.124.2x.jpeg 440w 30 May 2023
Sydney spinout lands $273m deal to develop drugs for psychiatric disorders

Compounds that target oxytocin receptors in the brain are being developed into medicines to treat schizophrenia and other psychiatric disorders in a landmark $273m partnership between �� spinout Kinoxis and Boehringer.
Article link /content/dam/people/crop-lowres-prof-michael-kassiou-(left)-and-associate-prof-michael-bowen-at-the-chau-chak-wing-museum.-03may23.-university-of-sydney.-photo-stefanie-zingsheim.jpg 800.350.2x.jpeg 1600w, 1280.1280.jpeg 1280w, 1440.630.2x.jpeg 2880w, 220.96.2x.jpeg 440w, 440.193.2x.jpeg 880w 05 May 2023
NSW Government backs University-led consortium on drug discovery

Professor Michael Kassiou from the Drug Discovery Initiative and School of Chemistry will lead the NSW Organoid Innovation Centre, which will focus on stem-cell science to accelerate precision medicine.
Article link /content/dam/intranet/images/medicine-and-health/news-and-events/2021/october-10/cortical-organoid-2.jpg 800.806.2x.jpeg 1600w, 1280.1280.jpeg 1280w, 220.222.2x.jpeg 440w, 440.443.2x.jpeg 880w 01 March 2023

������

Latest news

��